Showing results (251-260 of 498) with videos related to

Sort By:
Pageof 50
Blood|July 17, 2014
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensusMeletios A Dimopoulos, Efstathios Kastritis, Roger G Owen, et al.
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Circulation. Heart Failure|June 15, 2017
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)Mathew S Maurer, Perry Elliott, Giampaolo Merlini, et al.
Gastroenterology|May 8, 2004
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian familiesLaura Obici, Giovanni Palladini, Sofia Giorgetti, et al.
American Journal of Hematology|December 4, 2024
Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUSSilvia Mangiacavalli, Paolo Milani, Claudio Salvatore Cartia, et al.
Nature Communications|March 22, 2019
Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patientPaolo Swuec, Francesca Lavatelli, Masayoshi Tasaki, et al.
Leukemia Research|April 28, 2009
SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemiaStéphanie Poulain, Marjan Ertault, Xavier Leleu, et al.
Inorganic Chemistry|May 15, 2002
Synthesis, NMR, and X-ray crystallographic analysis of C-hydrazino-C-carboxycarboranes: versatile ligands for the preparation of BNCT and BNCS agents and (99m)Tc radiopharmaceuticalsJohn F Valliant, Oyebola O Sogbein, Pierre Morel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 12, 2010
Embryonic stem and haematopoietic progenitor cells resist to Aβ oligomer toxicity and maintain the differentiation potency in cultureTui Neri, Monica Bucciantini, Vittorio Rosti, et al.
American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.
Pageof 50